| RS79392371 |
LRBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to LRBA deficiency, LRBA-related disorder |
| RS79395563 |
BNC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS79400016 |
CACNA1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS79400048 |
PDE11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmented nodular adrenocortical disease, primary |
| RS79405108 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS79406408 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS79407758 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS79410539 |
COX15
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Leigh syndrome |
| RS79412180 |
RSPH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 12 |
| RS79414242 |
CHAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myasthenia, CHAT-related disorder |
| RS79424354 |
CNNM4
|
Health Risk |
Pathogenic |
Jalili syndrome, Jalili syndrome |
| RS79426098 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS79431304 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS79436363 |
WDR19
|
Health Risk |
Pathogenic/Likely pathogenic |
Senior-Loken syndrome 8, Asphyxiating thoracic dystrophy 5 |
| RS79439293 |
AUTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
AUTS2-related disorder, AUTS2-related disorder |
| RS79440238 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS79446920 |
IL12B
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency, Inborn genetic diseases |
| RS79456940 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS79457258 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS79457490 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS79469730 |
CASQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS794726653 |
VIPAS39
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS794726655 |
TSPAN12
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS794726656 |
PTS
|
Health Risk |
Pathogenic |
Hyperphenylalaninemia, bh4-deficient |
| RS794726658 |
VPS33B
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS794726659 |
SIL1
|
Health Risk |
Pathogenic |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS794726660 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS794726661 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS794726662 |
LCAT
|
Health Risk |
Pathogenic |
LCAT deficiency, LCAT deficiency |
| RS794726663 |
LCAT
|
Health Risk |
Pathogenic |
LCAT deficiency, LCAT deficiency |
| RS794726664 |
LCAT
|
Health Risk |
Pathogenic |
Fish-eye disease, Fish-eye disease |
| RS794726665 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS794726666 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS794726667 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group C, Fanconi anemia |
| RS794726668 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group C, Fanconi anemia |
| RS794726669 |
HSD11B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Apparent mineralocorticoid excess, mild |
| RS794726672 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism, Piebaldism |
| RS794726673 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism, Piebaldism |
| RS794726674 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism, Piebaldism |
| RS794726675 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism, Gastrointestinal stromal tumor |
| RS794726676 |
ITGB4
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Epidermolysis bullosa |
| RS794726677 |
MEGF10
|
Health Risk |
Pathogenic |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS794726678 |
MEGF10
|
Health Risk |
Pathogenic |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS794726679 |
MEGF10
|
Health Risk |
Pathogenic |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS794726680 |
ANO10
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 10, Autosomal recessive spinocerebellar ataxia 10 |
| RS794726681 |
ANO10
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 10, Autosomal recessive spinocerebellar ataxia 10 |
| RS794726682 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS794726683 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS794726684 |
HSD11B2
|
Health Risk |
Pathogenic |
Apparent mineralocorticoid excess, Apparent mineralocorticoid excess |
| RS794726685 |
GPR179
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1E, Congenital stationary night blindness 1E |
| RS794726686 |
GPR179
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1E, Congenital stationary night blindness 1E |
| RS794726688 |
ADAMTSL4
|
Health Risk |
Pathogenic |
Ectopia lentis 2, isolated |
| RS794726689 |
ADAMTSL4
|
Health Risk |
Pathogenic |
Ectopia lentis 2, isolated |
| RS794726691 |
TTC19
|
Health Risk |
Pathogenic |
Mitochondrial complex III deficiency nuclear type 2, Mitochondrial complex III deficiency nuclear type 2 |
| RS794726692 |
TTC19
|
Health Risk |
Pathogenic |
Mitochondrial complex III deficiency nuclear type 2, Mitochondrial complex III deficiency nuclear type 2 |
| RS794726693 |
PROP1
|
Health Risk |
Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS794726695 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726696 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726697 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Seizure |
| RS794726698 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726699 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726700 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726701 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726702 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726703 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726704 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726705 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726706 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726707 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726708 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS794726709 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726710 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Seizure |
| RS794726711 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Developmental and epileptic encephalopathy |
| RS794726712 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726713 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS794726714 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726716 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726717 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726718 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726719 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726720 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS794726721 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726722 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726723 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726724 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726725 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726726 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS794726727 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726728 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726729 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726730 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS794726731 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726732 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726733 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS794726734 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726735 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726736 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, SCN1A-related disorder |
| RS794726737 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726738 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS794726739 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |